Abstract:Abstract Background: Congenital heart disease (CHD) is one of the commonly seen malformations, with incidence varying from 7 to 8/1000 live birth. Causes are multifactorial. Routine examination of neonates may miss more than 50% of cases. Pulse oximetry is a simple, noninvasive, bedside test which estimates the percentage of oxygen bound to hemoglobin (oxygen saturation [SpO 2 ]). Detection of critical CHD (CCHD) has been possible with SpO 2 screening. Many countries included SpO 2 as part of newborn screening due to this. As a primary approach, both pre- and post-ductal extremity SpO 2 is measured after 24 h of life. Echocardiography (ECHO) will be done on neonates with SpO 2 readings <95%. Neonates born in high-altitude regions, studies have suggest to use adjusted threshold values. In India, there are limited studies. Aims: The aim of this study was to determine the usefulness of pulse oximetry as a screening tool for early detection of CHD in otherwise asymptomatic newborns. To determine, the accuracy of SpO 2 for detecting clinically unrecognized CCHD in newborns. Materials and Methods: This is a prospective observational study done in the department of pediatrics in a tertiary hospital. The study was conducted over 12 months. During the study period, all neonates born who fulfilled the inclusion criteria were included in the study. After 24 h of life, neonates were examined clinically and the pre- and post-ductal SpO 2 was measured. Neonates with SpO 2 <90% in room air were excluded from the study. If the SpO 2 was between 90% and 94%, clinical examination was repeated, if suspicious of CHD, they were referred for ECHO. If there was no suspicion of CHD, SpO 2 was repeated after 6 h and ECHO was done if SpO 2 ≤95. The difference of SpO 2 >3% between the right upper limb and right lower limb was considered positive. Positive neonates were evaluated with two-dimensional echocardiograph. Inclusion criteria - All hemodynamically stable neonates were born during the study period. Exclusion criteria (1) Antenatally diagnosed cardiac anomalies, (2) Outborn neonates, (3) Parents/guardians are not willing to participate in the study and/or further investigation, (4) Sick neonates and those with SpO 2 <90% at birth. Results: 1117 (83.7%) were eligible for the study out of 1333 neonates born. 669 (59.9%) were born by cesarean section and 448 (40.1%) by vaginal delivery. 996 (89.2%) were born at term (≥37 weeks of gestation) and 121 (10.8%) were preterm (<37 weeks of gestation). The male-to-female ratio was 1.03:1. The mean birth weight of the neonates was 2.91 ± 0.46 kg (mean ± standard deviation). The mean SPO 2 in the right upper limb was 96.62 ± 1.73, in the right lower limb was 96.87 ± 1.76, in the left upper limb was 96.59 ± 1.90, and in the left lower limb was 97.06 ± 1.74. The average SPO 2 difference between the right upper limb and right lower limb was 1.04 ± 1.07. Based on SpO 2, 858 (76.8%) cases were not suspected of having CHD and 259 (23.3%) were suspected of having CHD and were evaluated with ECHO. Six (0.5%) neonates had CHD in whom echo was done. In our study, for detecting CCHD, SPO 2 cutoff value of ≤90% showed 90% sensitivity, 99.94% specificity, 75% positive predictive value, and 99.98% negative predictive value. Conclusions: This study emphasizes noninvasive SPO 2 as reliable and feasible, with good negative predictive value screening for CHD in neonates.

Nucleated Red Blood Cell Counts Differentiate Cardiac from Respiratory Causes of Cyanosis at Birth

Neonatal hyperbilirubinemia management: Clinical assessment of bilirubin production.

Reference ranges for blood concentrations of nucleated red blood cells in neonates

Differences in Cerebral Tissue Oxygenation in Preterm Neonates Receiving Adult or Cord Blood Red Blood Cell Transfusions

Circulating Nucleated Red Blood Cells: An Updated Reference Interval

Role of Pulse Oximetry as a Screening Tool for the Detection of Congenital Heart Disease in Newborn Babies

Comparison Evaluation of Automated Nucleated Red Blood Cell Enumeration by Sysmex XN 1000 in Comparison With Microscopic Reference in Children Under 1 Year

Cerebral Oxygen Saturation in Children With Congenital Heart Disease and Chronic Hypoxemia

Nucleated red blood cells are a late biomarker in predicting intensive care unit mortality in patients with COVID-19 acute respiratory distress syndrome: an observational cohort study

Pulse Oximetry Screening for Detecting Critical Congenital Heart Disease in Neonates

Absolute reticulocyte count at birth and outcome of neonates with persistent pulmonary hypertension.

Nucleated red blood cells as a novel biomarker in the diagnosis and prediction of sepsis severity in children

Association of Neutrophil-Lymphocyte Ratio and Red Blood Cell Distribution Width with Poor Outcome in Pediatric Cardiac Surgery - A Retrospective Observational Study

Neonatal Pulse Oxymetry Screening for Detection of Congenital Heart Disease in Asymptomatic Newborns: A Cross-sectional Study from a Tertiary Care Hospital

Improving diagnostic accuracy in the transport of infants with suspected duct-dependent congenital heart disease

Brain-Type Natriuretic Peptide in the Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn

Racial, ethnic, and socio-economic disparities in neonatal ICU admissions among neonates born with cyanotic CHD in the United States, 2009–2018

Critical congenital heart disease screening by pulse oximetry in a neonatal intensive care unit

Impact of fetal development on neurocognitive performance of adolescents with cyanotic and acyanotic congenital heart disease

Neonatal Pulse Oximetry Screening for Congenital Heart Disease

Umbilical Cord Blood as an Alternative to Neonatal Blood for Complete Blood Count: A Comparison Study